Nuvalent Inc - Class A — Dividend History & Yield (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Notizie

Nuvalent registra perdite nel Q4, attende decisione FDA su farmaco anticancro

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Il titolo di Nuvalent Inc raggiunge il massimo di 52 settimane a 112,89 USD

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA accetta la domanda di Nuvalent per il trattamento del NSCLC ROS1-positivo

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts